KALA BIO, Inc.
KALA
Clasificación en acciones
#30743
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the... Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
Precio por acción
$0.75
Última sincronización: 2026-07-31
Capitalización bursátil
$14.50M
Cambio (1 día)
2.78%
Cambio (1 año)
-98.28%
País
US
Comercio KALA BIO, Inc. (KALA)
Categoría
Healthcare
Historial del precio de la acción de KALA BIO, Inc. (KALA)
Precio más alto de cierre: $0.28 el 2026-10-01
Precio más bajo de cierre: $37.46K el 2018-01-01
Precio más bajo de cierre: $37.46K el 2018-01-01
Historial del precio de la acción de KALA BIO, Inc. desde 2018 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | -64.03% |
| 2025 | -88.09% |
| 2024 | -12.41% |
| 2023 | -37.21% |
| 2022 | -84.21% |
| 2021 | -79.90% |
| 2020 | 49.13% |
| 2019 | 15.30% |
| 2018 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $536.47 | 25.80% |
US
|
|
| $187.21 | 597.24% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $883.47 | 8.51% |
NL
|
